Benoit Gourdier - Feb 23, 2024 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
/s/ Scott K. Baker, as Attorney-in-Fact
Stock symbol
AVTR
Transactions as of
Feb 23, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 05:02 PM
Previous filing
Oct 4, 2023
Next filing
Oct 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Award $0 +25.7K +152.91% $0.00 42.5K Feb 23, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTR Stock Options (Right to Buy) Award $0 +62.8K $0.00 62.8K Feb 23, 2024 Common Stock 62.8K $24.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 23, 2025.
F2 Reflects a grant of stock options that vest in three equal annual installments beginning on February, 23, 2025.